Chandra Bartholomeusz

2.9k citations
44 papers · 2.0k indexed · 1 hit paper · h-index 24
Topics
HER2/EGFR in Cancer Research (9 papers)Cancer-related Molecular Pathways (9 papers)Melanoma and MAPK Pathways (7 papers)

In The Last Decade

Chandra Bartholomeusz

42 papers receiving 2.0k citations

Hit Papers

Role of epidermal growth factor receptor in breast cancer20122026201620212012200400600

Peers

Chandra Bartholomeusz
Comparison fields: 5 of 95
  • Molecular Biology 1.2k
  • Oncology 867
  • Cancer Research 416
  • Pulmonary and Respiratory Medicine 321
  • Organic Chemistry 166
Replace Sheng-Chieh Hsu with:
Sheng-Chieh Hsu Taiwan
Carolyn Cao United States
Nhu‐An Pham Canada
Rebecca E. Schweppe United States
Mei‐Chih Liang United States
Lacey E. Dobrolecki United States
Marc Lacroix Belgium
Y.N. Vashisht Gopal United States
Anette Sommer Germany
Doris R. Siwak United States
Chandra Bartholomeusz relative to Sheng-Chieh Hsu Taiwan Sheng-Chieh Hsu's profile →
Citations per field
00.5×3.3×
Sheng-Chieh Hsu · 1×
Citations per year

Countries citing papers authored by Chandra Bartholomeusz

Since Specialization
Citations

This map shows the geographic impact of Chandra Bartholomeusz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chandra Bartholomeusz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chandra Bartholomeusz more than expected).

Fields of papers citing papers by Chandra Bartholomeusz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chandra Bartholomeusz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chandra Bartholomeusz. The network helps show where Chandra Bartholomeusz may publish in the future.

Co-authorship network of co-authors of Chandra Bartholomeusz

This figure shows the co-authorship network connecting the top 25 collaborators of Chandra Bartholomeusz. A scholar is included among the top collaborators of Chandra Bartholomeusz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chandra Bartholomeusz. Chandra Bartholomeusz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 20
4 28
5 20
6 29
7 78
8 59
9 50
10 26
11 43
12 9
13 8
14 22
15 23
16 12
17 20
18 60
19 69
20
E1A-mediated paclitaxel sensitization in HER-2/neu-overexpressing ovarian cancer SKOV3.ip1 through apoptosis involving the caspase-3 pathway.
82

About Chandra Bartholomeusz

Chandra Bartholomeusz is a scholar working on Oncology, Biotechnology and Immunology and Allergy, having authored 44 papers that have together received 2.0k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (9 papers), Cancer-related Molecular Pathways (9 papers) and Melanoma and MAPK Pathways (7 papers). The work is most often cited by research in Oncology (867 citations), Cancer Research (416 citations) and Molecular Biology (1.2k citations). Chandra Bartholomeusz has collaborated with scholars based in United States, Japan and United Kingdom. Frequent co-authors include Naoto T. Ueno, Gabriel N. Hortobágyi, Dongwei Zhang, Ana M. González-Angulo, Hiroko Masuda, Hiroyoshi Doihara, Fumiyuki Yamasaki, Kevin N. Dalby, Francisco J. Esteva and Kaoru Kurisu. Their work appears in journals such as Cancer Research, Oncogene and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026